A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
for Advanced Prostate Cancer
Sites in Scottsdale +1 more location
Sponsor: Genentech, Inc.
Sex: Male·Age: 18+
Code: NCT07567846·Phase 1, Phase 2·Recruiting·Listed May 2026